Observational studyOncology research and treatment2023

Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials.

Linda Katharina Zöhrlaut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.